342 related articles for article (PubMed ID: 29760157)
1. Methyl-CpG-binding protein 2 mediates antifibrotic effects in scleroderma fibroblasts.
He Y; Tsou PS; Khanna D; Sawalha AH
Ann Rheum Dis; 2018 Aug; 77(8):1208-1218. PubMed ID: 29760157
[TBL] [Abstract][Full Text] [Related]
2. Methyl cap binding protein 2: a key epigenetic protein in systemic sclerosis.
Henderson J; Brown M; Horsburgh S; Duffy L; Wilkinson S; Worrell J; Stratton R; O'Reilly S
Rheumatology (Oxford); 2019 Mar; 58(3):527-535. PubMed ID: 30462328
[TBL] [Abstract][Full Text] [Related]
3. Progranulin Overproduction Due to Fli-1 Deficiency Contributes to the Resistance of Dermal Fibroblasts to Tumor Necrosis Factor in Systemic Sclerosis.
Ichimura Y; Asano Y; Akamata K; Noda S; Taniguchi T; Takahashi T; Toyama T; Tada Y; Sugaya M; Sato S; Kadono T
Arthritis Rheumatol; 2015 Dec; 67(12):3245-55. PubMed ID: 26245842
[TBL] [Abstract][Full Text] [Related]
4. Chemokine receptor CCR2 expression by systemic sclerosis fibroblasts: evidence for autocrine regulation of myofibroblast differentiation.
Carulli MT; Ong VH; Ponticos M; Shiwen X; Abraham DJ; Black CM; Denton CP
Arthritis Rheum; 2005 Dec; 52(12):3772-82. PubMed ID: 16320328
[TBL] [Abstract][Full Text] [Related]
5. MeCP2 epigenetically regulates alpha-smooth muscle actin in human lung fibroblasts.
Xiang Z; Zhou Q; Hu M; Sanders YY
J Cell Biochem; 2020 Jul; 121(7):3616-3625. PubMed ID: 32115750
[TBL] [Abstract][Full Text] [Related]
6. Dipeptidylpeptidase 4 as a Marker of Activated Fibroblasts and a Potential Target for the Treatment of Fibrosis in Systemic Sclerosis.
Soare A; Györfi HA; Matei AE; Dees C; Rauber S; Wohlfahrt T; Chen CW; Ludolph I; Horch RE; Bäuerle T; von Hörsten S; Mihai C; Distler O; Ramming A; Schett G; Distler JHW
Arthritis Rheumatol; 2020 Jan; 72(1):137-149. PubMed ID: 31350829
[TBL] [Abstract][Full Text] [Related]
7. Histone Deacetylase 5 Is Overexpressed in Scleroderma Endothelial Cells and Impairs Angiogenesis via Repression of Proangiogenic Factors.
Tsou PS; Wren JD; Amin MA; Schiopu E; Fox DA; Khanna D; Sawalha AH
Arthritis Rheumatol; 2016 Dec; 68(12):2975-2985. PubMed ID: 27482699
[TBL] [Abstract][Full Text] [Related]
8. Decreased cathepsin V expression due to Fli1 deficiency contributes to the development of dermal fibrosis and proliferative vasculopathy in systemic sclerosis.
Noda S; Asano Y; Takahashi T; Akamata K; Aozasa N; Taniguchi T; Ichimura Y; Toyama T; Sumida H; Kuwano Y; Yanaba K; Tada Y; Sugaya M; Kadono T; Sato S
Rheumatology (Oxford); 2013 May; 52(5):790-9. PubMed ID: 23287360
[TBL] [Abstract][Full Text] [Related]
9. MeCP2 regulation of cardiac fibroblast proliferation and fibrosis by down-regulation of DUSP5.
Tao H; Yang JJ; Hu W; Shi KH; Deng ZY; Li J
Int J Biol Macromol; 2016 Jan; 82():68-75. PubMed ID: 26511729
[TBL] [Abstract][Full Text] [Related]
10. A possible contribution of visfatin to the resolution of skin sclerosis in patients with diffuse cutaneous systemic sclerosis via a direct anti-fibrotic effect on dermal fibroblasts and Th1 polarization of the immune response.
Masui Y; Asano Y; Shibata S; Noda S; Akamata K; Aozasa N; Taniguchi T; Takahashi T; Ichimura Y; Toyama T; Sumida H; Yanaba K; Tada Y; Sugaya M; Sato S; Kadono T
Rheumatology (Oxford); 2013 Jul; 52(7):1239-44. PubMed ID: 23443327
[TBL] [Abstract][Full Text] [Related]
11. Scleroderma keratinocytes promote fibroblast activation independent of transforming growth factor beta.
McCoy SS; Reed TJ; Berthier CC; Tsou PS; Liu J; Gudjonsson JE; Khanna D; Kahlenberg JM
Rheumatology (Oxford); 2017 Nov; 56(11):1970-1981. PubMed ID: 28968684
[TBL] [Abstract][Full Text] [Related]
12. Genome-Wide Reduction in Chromatin Accessibility and Unique Transcription Factor Footprints in Endothelial Cells and Fibroblasts in Scleroderma Skin.
Tsou PS; Palisoc PJ; Ali M; Khanna D; Sawalha AH
Arthritis Rheumatol; 2021 Aug; 73(8):1501-1513. PubMed ID: 33586346
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of the N-formyl Peptide receptors in scleroderma fibroblasts fosters the switch to myofibroblasts.
Rossi FW; Napolitano F; Pesapane A; Mascolo M; Staibano S; Matucci-Cerinic M; Guiducci S; Ragno P; di Spigna G; Postiglione L; Marone G; Montuori N; de Paulis A
J Immunol; 2015 Jun; 194(11):5161-73. PubMed ID: 25917089
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic reader MeCP2 repressed WIF1 boosts lung fibroblast proliferation, migration and pulmonary fibrosis.
Sha JM; Zhang RQ; Wang XC; Zhou Y; Song K; Sun H; Tu B; Tao H
Toxicol Lett; 2023 May; 381():1-12. PubMed ID: 37061208
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic factors MeCP2 and HDAC6 control α-tubulin acetylation in cardiac fibroblast proliferation and fibrosis.
Tao H; Yang JJ; Shi KH; Li J
Inflamm Res; 2016 May; 65(5):415-26. PubMed ID: 26975406
[TBL] [Abstract][Full Text] [Related]
16. Effect of MeCP2 on TGF- β1-induced Extracellular Matrix Production in Nasal Polyp-derived Fibroblasts.
Shin JM; Um JY; Lee SA; Park IH; Lee SH; Lee HM
Am J Rhinol Allergy; 2018 Jul; 32(4):228-235. PubMed ID: 29676176
[TBL] [Abstract][Full Text] [Related]
17. Nintedanib inhibits fibroblast activation and ameliorates fibrosis in preclinical models of systemic sclerosis.
Huang J; Beyer C; Palumbo-Zerr K; Zhang Y; Ramming A; Distler A; Gelse K; Distler O; Schett G; Wollin L; Distler JH
Ann Rheum Dis; 2016 May; 75(5):883-90. PubMed ID: 25858641
[TBL] [Abstract][Full Text] [Related]
18. Interferon-γ Induces Interleukin-6 Production and Alpha-smooth Muscle Actin Expression in Systemic Sclerosis Fibroblasts.
Rokni M; Farhadi E; Kavosi H; Akhtari M; Madreseh E; Enayati S; Sadeghi Shaker M; Mostafaei S; Gharibdoost F; Mahmoudi M; Vodjgani M
Iran J Allergy Asthma Immunol; 2024 Apr; 23(2):197-220. PubMed ID: 38822514
[TBL] [Abstract][Full Text] [Related]
19. Regulation of Fibroblast Apoptosis and Proliferation by MicroRNA-125b in Systemic Sclerosis.
Kozlova A; Pachera E; Maurer B; Jüngel A; Distler JHW; Kania G; Distler O
Arthritis Rheumatol; 2019 Dec; 71(12):2068-2080. PubMed ID: 31309742
[TBL] [Abstract][Full Text] [Related]
20. Lipoic acid plays a role in scleroderma: insights obtained from scleroderma dermal fibroblasts.
Tsou PS; Balogh B; Pinney AJ; Zakhem G; Lozier A; Amin MA; Stinson WA; Schiopu E; Khanna D; Fox DA; Koch AE
Arthritis Res Ther; 2014; 16(5):411. PubMed ID: 25123250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
